Singapore Med J 2014; 55(6): 293; http://dx.doi.org/10.11622/smedj.2014075
Respiratory precautions for MERS-CoV: acceptable risk-benefit determination
Hsu LY
Correspondence: Dr Hsu Li Yang, li_yang_hsu@nuhs.edu.sg
As of May 29, 2014, there have been 636 laboratoryconfirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV), with 193 deaths, which translates into a case fatality rate of 30.3%.(1) There is currently no specific treatment for the infection other than supportive medical care. The majority of recent cases appeared to arise from human-to-human transmission and have mainly occurred within the healthcare setting.(2) Although Singapore has had no MERS-CoV cases to date, we remain at continued risk for MERS-CoV importation in view of the significant number of travellers to and from the Middle East for religious (i.e. Umrah and Hajj), recreational, medical and business purposes.
Singapore Med J 2014; 55(6): 293; http://dx.doi.org/10.11622/smedj.2014075
REFERENCES
1. Australian Government Department of Health. Middle East respiratory syndrome coronavirus (MERS-CoV): situation update 29 May 2014. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-mers-c...$file/mers-cov-situpdate-20140529.pdf. | | 2. World Health Organization. WHO risk assessment: Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_201404.... | | 3. Chung SJ, Ling ML, Seto WH, Ang BS, Tambyah PA. Debate on MERS-CoV respiratory precautions: surgical mask or N95 respirators? Singapore Med J 2014; 55:294-7. http://dx.doi.org/10.11622/smedj.2014076 | | 4. Lee HP, Wang de Y. Objective assessment of increase in breathing resistance of N95 respirators on human subjects. Ann Ocup Hyg 2011; 55:917-21. http://dx.doi.org/10.1093/annhyg/mer065 | | 5. Lim EC, Seet RC, Lee KH, et al. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand 2006; 113:199-202. http://dx.doi.org/10.1111/j.1600-0404.2005.00560.x | | 6. Foo CC, Goon AT, Leow YH, Goh CL. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome – a descriptive study in Singapore. Contact Dermatitis 2006; 55:291-4. http://dx.doi.org/10.1111/j.1600-0536.2006.00953.x | | 7. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2011; (7):CD006207. | | |